Skip to main content
Erschienen in: Rheumatology International 1/2013

01.01.2013 | Short Communication

The effects of combined spa therapy and rehabilitation on patients with ankylosing spondylitis being treated with TNF inhibitors

verfasst von: Luca Ciprian, Alessandro Lo Nigro, Michela Rizzo, Alessandra Gava, Roberta Ramonda, Leonardo Punzi, Franco Cozzi

Erschienen in: Rheumatology International | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Despite advances in pharmacological therapy, physical treatment continues to be important in the management of ankylosing spondylitis (AS). The objective of the present study was to evaluate the effects and tolerability of combined spa therapy and rehabilitation in a group of AS patients being treated with TNF inhibitors. Thirty AS patients attending the Rheumatology Unit of the University of Padova being treated with TNF inhibitors for at least 3 months were randomized and assessed by an investigator independent from the spa staff: 15 were prescribed 10 sessions of spa therapy (mud packs and thermal baths) and rehabilitation (exercises in a thermal pool) and the other 15 were considered controls. The patients in both groups had been receiving anti-TNF agents for at least three months. The outcome measures utilized were BASFI, BASDAI, BASMI, VAS for back pain and HAQ. The evaluations were performed in all patients at the entry to the study, at the end of the spa treatment, and after 3 and 6 months. Most of the evaluation indices were significantly improved at the end of the spa treatment, as well as at the 3 and 6 months follow-up assessments. No significant alterations in the evaluation indices were found in the control group. Combined spa therapy and rehabilitation caused a clear, long-term clinical improvement in AS patients being treated with TNF inhibitors. Thermal treatment was found to be well tolerated and none of the patients had disease relapse.
Literatur
2.
Zurück zum Zitat Dagfinrud HJ, Kvien TK, Hagen KB (2005) The Cochrane review of physioterapy interventions for ankylosing spondylitis. J Rheumatol 32:1899–1906PubMed Dagfinrud HJ, Kvien TK, Hagen KB (2005) The Cochrane review of physioterapy interventions for ankylosing spondylitis. J Rheumatol 32:1899–1906PubMed
3.
Zurück zum Zitat Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, Cannon GW et al (1996) Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39:2004–2012PubMedCrossRef Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, Cannon GW et al (1996) Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39:2004–2012PubMedCrossRef
4.
Zurück zum Zitat Biasi D, Carletto A, Caramaschi P, Pacor ML, Maleknia T, Bambara LM (2009) Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study. Clin Rheumatol 19:114–117CrossRef Biasi D, Carletto A, Caramaschi P, Pacor ML, Maleknia T, Bambara LM (2009) Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study. Clin Rheumatol 19:114–117CrossRef
5.
Zurück zum Zitat Haibel H, Sieper J (2010) Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker? Curr Opin Rheumatol 22:388–392PubMedCrossRef Haibel H, Sieper J (2010) Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker? Curr Opin Rheumatol 22:388–392PubMedCrossRef
6.
Zurück zum Zitat Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC, Dijkmans B et al (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65:442–452PubMedCrossRef Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC, Dijkmans B et al (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65:442–452PubMedCrossRef
7.
Zurück zum Zitat Dagfinrud H, Kvien TK, Hagen KB (2008) Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 1:CD002822PubMed Dagfinrud H, Kvien TK, Hagen KB (2008) Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 1:CD002822PubMed
8.
Zurück zum Zitat Van Tubergen A, Van der Linden S (2002) A brief history of spa therapy. Ann Rheum Dis 61:273–275PubMedCrossRef Van Tubergen A, Van der Linden S (2002) A brief history of spa therapy. Ann Rheum Dis 61:273–275PubMedCrossRef
9.
Zurück zum Zitat Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J et al (2009) The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783PubMedCrossRef Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J et al (2009) The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783PubMedCrossRef
10.
Zurück zum Zitat Codish S, Dobrovinsky S, Abu Shakra M, Flusser D, Sukenik S (2005) Spa therapy for ankylosing spondylitis at the Dead Sea. Isr Med Assoc J 7:443–446PubMed Codish S, Dobrovinsky S, Abu Shakra M, Flusser D, Sukenik S (2005) Spa therapy for ankylosing spondylitis at the Dead Sea. Isr Med Assoc J 7:443–446PubMed
11.
Zurück zum Zitat Yurtkuran M, Ay A, Karakoc Y (2005) Improvement of the clinical outcome in ankylosing spondylitis by balneotherapy. Joint Bone Spine 72:303–308PubMedCrossRef Yurtkuran M, Ay A, Karakoc Y (2005) Improvement of the clinical outcome in ankylosing spondylitis by balneotherapy. Joint Bone Spine 72:303–308PubMedCrossRef
12.
Zurück zum Zitat Altan L, Bingol U, Aslan M, Yurtkuran M (2006) The effect of balneotherapy on patients with ankylosing spondylitis. Scand J Rheumatol 35:283–289PubMedCrossRef Altan L, Bingol U, Aslan M, Yurtkuran M (2006) The effect of balneotherapy on patients with ankylosing spondylitis. Scand J Rheumatol 35:283–289PubMedCrossRef
13.
Zurück zum Zitat Elkayam O, Ophir J, Brener S, Paran D, Wigler I, Efron D et al (2000) Immediate and delayed effects of treatment at the Dead Sea in patients with psoriatic arthritis. Rheumatol Int 19:77–82PubMedCrossRef Elkayam O, Ophir J, Brener S, Paran D, Wigler I, Efron D et al (2000) Immediate and delayed effects of treatment at the Dead Sea in patients with psoriatic arthritis. Rheumatol Int 19:77–82PubMedCrossRef
14.
Zurück zum Zitat Cozzi F, Podswiadek M, Cardinale G, Oliviero F, Dani L, Sfriso P et al (2007) Mud-bath treatment in spondylitis associated with inflammatory bowel disease—a pilot randomized clinical trial. Joint Bone Spine 74:436–439PubMedCrossRef Cozzi F, Podswiadek M, Cardinale G, Oliviero F, Dani L, Sfriso P et al (2007) Mud-bath treatment in spondylitis associated with inflammatory bowel disease—a pilot randomized clinical trial. Joint Bone Spine 74:436–439PubMedCrossRef
15.
Zurück zum Zitat Dubey SG, Leeder J, Gaffney K (2008) Physical therapy in anti-TNF treated patients with ankylosing spondylitis. Rheumatology 47:1100–1101PubMedCrossRef Dubey SG, Leeder J, Gaffney K (2008) Physical therapy in anti-TNF treated patients with ankylosing spondylitis. Rheumatology 47:1100–1101PubMedCrossRef
16.
Zurück zum Zitat Van Tubergen A, Landewé R, van der Heijde D, Hidding A, Wolter N, Asscher M et al (2001) Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum 45:430–438PubMedCrossRef Van Tubergen A, Landewé R, van der Heijde D, Hidding A, Wolter N, Asscher M et al (2001) Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum 45:430–438PubMedCrossRef
17.
Zurück zum Zitat Colina M, Ciancio G, Garavini R, Conti M, Trotta F, Govoni M (2009) Combination treatment with etanercept and an intensive spa rehabilitation program in active ankylosing spondylitis. Int J Immunopathol Pharmacol 22:1125–1129PubMed Colina M, Ciancio G, Garavini R, Conti M, Trotta F, Govoni M (2009) Combination treatment with etanercept and an intensive spa rehabilitation program in active ankylosing spondylitis. Int J Immunopathol Pharmacol 22:1125–1129PubMed
18.
Zurück zum Zitat Giusti P, Cima L, Tinello A, Cozzi F, Targa L, Lazzarin P et al (1990) Stresshormone, freigesetzt durch Fangotherapie. ACTH- und Beta-Endorphin-Konzentrationen unter Wärmestress. Fortsch Med 108:601–604 Giusti P, Cima L, Tinello A, Cozzi F, Targa L, Lazzarin P et al (1990) Stresshormone, freigesetzt durch Fangotherapie. ACTH- und Beta-Endorphin-Konzentrationen unter Wärmestress. Fortsch Med 108:601–604
19.
Zurück zum Zitat Cozzi F, Lazzarin P, Todesco S, Cima L (1995) Hypothalamic-pituitary-adrenal axis dysregulation in healthy subjects undergoing mud-bath applications. Arthritis Rheum 38:724–725PubMedCrossRef Cozzi F, Lazzarin P, Todesco S, Cima L (1995) Hypothalamic-pituitary-adrenal axis dysregulation in healthy subjects undergoing mud-bath applications. Arthritis Rheum 38:724–725PubMedCrossRef
20.
Zurück zum Zitat Cozzi F, Carrara M, Sfriso P, Todesco S, Cima L (2004) Anti-inflammatory effect of mud-bath applications on adjuvant arthritis in rats. Clin Exp Rheumatol 22:763–766PubMed Cozzi F, Carrara M, Sfriso P, Todesco S, Cima L (2004) Anti-inflammatory effect of mud-bath applications on adjuvant arthritis in rats. Clin Exp Rheumatol 22:763–766PubMed
21.
Zurück zum Zitat Britschka ZM, Teodoro WR, Velosa AP, de Mello SB (2007) The efficacy of Brazilian black mud treatment in chronic experimental arthritis. Rheumatol Int 28:39–45PubMedCrossRef Britschka ZM, Teodoro WR, Velosa AP, de Mello SB (2007) The efficacy of Brazilian black mud treatment in chronic experimental arthritis. Rheumatol Int 28:39–45PubMedCrossRef
22.
Zurück zum Zitat Schmidt KL (1991) Physical therapy and balneotherapy of arthritis. Ther Umsch 48:46–51PubMed Schmidt KL (1991) Physical therapy and balneotherapy of arthritis. Ther Umsch 48:46–51PubMed
23.
Zurück zum Zitat Kappel M, Gyhrs A, Galbo H, Pedersen BK (1997) The response on glucoregulatory hormones of in vivo whole body hyperthermia. Int J Hyperthermia 13:413–421PubMedCrossRef Kappel M, Gyhrs A, Galbo H, Pedersen BK (1997) The response on glucoregulatory hormones of in vivo whole body hyperthermia. Int J Hyperthermia 13:413–421PubMedCrossRef
24.
Zurück zum Zitat Bender T, Karagülle Z, Bálint GP, Gutenbrunner C, Bálint PV, Sukenik S (2005) Hydrotherapy, balneotherapy, and spa treatment in pain management. Rheumatol Int 25:220–224PubMedCrossRef Bender T, Karagülle Z, Bálint GP, Gutenbrunner C, Bálint PV, Sukenik S (2005) Hydrotherapy, balneotherapy, and spa treatment in pain management. Rheumatol Int 25:220–224PubMedCrossRef
Metadaten
Titel
The effects of combined spa therapy and rehabilitation on patients with ankylosing spondylitis being treated with TNF inhibitors
verfasst von
Luca Ciprian
Alessandro Lo Nigro
Michela Rizzo
Alessandra Gava
Roberta Ramonda
Leonardo Punzi
Franco Cozzi
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 1/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2147-9

Weitere Artikel der Ausgabe 1/2013

Rheumatology International 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.